Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/1995
10/12/1995WO1995025509A3 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity
10/12/1995WO1995024928A3 Heparin-binding growth factors for gene therapy and anterior eye disorders
10/12/1995CA2187166A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995CA2186734A1 Ophthalmic composition with decreased viscosity
10/12/1995CA2186591A1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity
10/12/1995CA2185699A1 Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
10/11/1995CN1109880A 3-(2-aminoethyl)-4-|3-(trifluoromethyl) benzoyl¨-3,4-dihydro-1,4-benzoxazine derivative and preparation of same
10/10/1995US5457237 Used in treating cancer and-or atherosclerosis
10/10/1995US5457131 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents
10/05/1995WO1995026409A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF)
10/05/1995WO1995026360A1 Antagonists of endothelin receptors
10/05/1995WO1995026351A1 1,2,4-TRIAZOLO[4,3-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026346A1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
10/05/1995CA2184755A1 Recombinant adenoviruses coding for basic fibroblast growth factors (bfgf)
10/05/1995CA2183767A1 Antagonists of endothelin receptors
10/04/1995EP0675110A1 1H-Indole-3-glyoxylamide sPLA2 inhibitors
10/04/1995EP0618905B1 Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists
10/04/1995CN1109332A New use of benzo|g¨quinolines
10/03/1995US5455252 Optionally substituted 6,8-quinolines
09/1995
09/28/1995WO1995025736A1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity
09/28/1995WO1995025726A1 QUINAZOLINYL-AMINO DERIVATIVES HAVING α-ANTAGONIST ACTIVITY
09/28/1995WO1995025543A1 Methods and compositions useful for inhibition of angiogenesis
09/28/1995WO1995025509A2 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity
09/27/1995EP0674007A1 Process for the preparation of pilocarpine
09/27/1995EP0673938A2 Novel purine derivatives and pharmaceutically acceptable salts thereof
09/27/1995EP0673421A1 Allergenic proteins and peptides from johnson grass pollen
09/27/1995EP0673367A1 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperidines as tachykinin receptor antagonists
09/27/1995EP0673250A1 Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis
09/27/1995CN1109057A 咪唑并哒嗪 Imidazopyridazine
09/27/1995CN1109056A Imidazopyridines
09/26/1995US5453488 Amino-substituted heterocycles as renin inhibitors
09/26/1995CA2145432A1 Purine derivatives and pharmaceutically acceptable salts thereof
09/22/1995CA2144898A1 Pilocarpin production process
09/21/1995WO1995024928A2 Heparin-binding growth factors for gene therapy and anterior eye disorders
09/21/1995WO1995024918A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases
09/21/1995WO1995024902A1 Ocular tension depressant
09/21/1995CA2185671A1 Heparin-binding growth factors for gene therapy and anterior eye disorders
09/20/1995EP0672417A1 Reduction of elevated intraocular pressure
09/20/1995EP0672055A1 Neuropeptide y antagonists
09/20/1995EP0671910A1 Glaucoma treatment
09/20/1995EP0671879A1 Prevention of retinal injury and degeneration by specific factors
09/19/1995US5451587 3-(2-propynyloxy)-1-azabicyclo(2.2.2)octane for treating alzheimer*s disease
09/14/1995WO1995024473A1 Vascular endothelial growth factor 2
09/14/1995WO1995024466A1 Transforming growth factor alpha h1
09/14/1995WO1995024398A1 Isoxazoline compounds as inhibitors of tnf release
09/14/1995WO1995024208A1 Glioblastoma-derived angiogenesis inhibiting factor
09/14/1995WO1995024192A1 Isoxazoline compounds as 5-lipoxygenase inhibitors
09/14/1995WO1995024186A1 Sulfonamide derivatives and their use
09/14/1995CA2414016A1 Vascular endothelial growth factor 2
09/14/1995CA2184583A1 Transforming growth factor alpha h1
09/14/1995CA2184358A1 Glioblastoma-derived angiogenesis inhibiting factor
09/14/1995CA2183428A1 Sulfonamide derivatives and their use
09/13/1995EP0670833A1 Nitroxy compounds with pharmaceutical properties
09/13/1995EP0670826A1 Fatty acid derivatives and pharmaceutical compositions containing them
09/13/1995EP0670733A1 Compositions containing growth factors and antiplastic agents
09/13/1995EP0670732A1 Compositions containing growth factors and antimetabolites
09/13/1995EP0670729A1 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs
09/08/1995WO1995023789A1 Bicyclic carbamates as leukotriene d4 antagonists
09/08/1995WO1995023601A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
09/06/1995EP0669936A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
09/06/1995EP0669833A1 USES OF TGF-$g(b) RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT
09/06/1995EP0544899B1 Prostaglandins
09/05/1995US5447928 Antiischemic agents and nervous system disorders
09/05/1995CA1336912C Phosphoric acid diesters and salts thereof
08/1995
08/31/1995WO1995022966A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
08/31/1995WO1995022965A2 Nasal and ocular administration of ketamine to manage pain and for detoxification
08/31/1995CA2184093A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
08/30/1995EP0669333A1 New imidazopyridine derivatives as angiotensin II antagonists
08/30/1995EP0668864A1 Substituted biphenylmethylimidazopyridines
08/30/1995CN1107639A Pyridothiazineacetic acid compound, process for producing the same, and use thereof
08/29/1995US5446041 Applying to treat glaucoma with reduced side effects
08/29/1995CA1336817C Angiogenesis inhibitor
08/25/1995CA2143412A1 Imidazopyridine derivatives as angiotensin ii antagonists
08/23/1995EP0667855A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
08/23/1995EP0667779A1 Ophthalmic solution and method of use
08/23/1995CN1107149A 哌嗪衍生物 Piperazine derivatives
08/23/1995CN1107054A Oral medicine for curing vision
08/22/1995US5444081 Treatment of hypertension, congestive heart failure, renal failure, glaucoma
08/22/1995US5444080 Hypotensive agents
08/22/1995US5444056 Aminoalkoxyphenyl derivatives, process for their preparation and compositions containing them
08/22/1995US5443833 Pharmaceutical compositions
08/22/1995CA2032231C Substituted oxophthalazinyl acetic acids and analogs thereof
08/17/1995WO1995021840A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
08/17/1995WO1995021839A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
08/17/1995WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
08/17/1995WO1995021610A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors
08/17/1995WO1995021609A1 Treatment of normotensive glaucoma with angiotensin ii antagonists
08/17/1995CA2181461A1 Treatment of normotensive glaucoma with angiotensin ii antagonists
08/16/1995EP0666849A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis
08/16/1995EP0372071B1 Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction
08/15/1995US5442110 Connective tissue disorders
08/15/1995US5441977 Immunosuppressive agent; for treating transplant rejection
08/15/1995US5441959 Hypotensive agents; treating congestive heart failure and glaucoma,inhibiting restenosis
08/15/1995US5441958 Allergic conjunctivitis
08/15/1995CA1336678C Prophylaxis and treatment of nervous system diseases with melanin
08/10/1995WO1995020971A1 Therapeutic composition for replacing and/or supplementing body fluids
08/09/1995EP0666260A1 3-(2-aminoethyl)-4-3-(trifluoromethyl)benzoyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, their preparation and use in therapy
08/09/1995EP0665752A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
08/09/1995EP0665751A1 Novel 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amines, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
08/09/1995EP0665744A1 Stable extended release oral dosage composition
1 ... 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 ... 531